Shannon L. Maude
Children's Hospital of Philadelphia
2 papers in the Anchorcite directory, published between 2014 and 2018, cited 11,410 times in total.
ORCID profileResearch topics
- CAR-T cell therapy research · 2 papers
- Immunotherapy and Immune Responses · 2 papers
- Acute Lymphoblastic Leukemia research · 2 papers
Frequent co-authors
- Carl H. June · 2 papers
- Bruce L. Levine · 2 papers
- Stephan A. Grupp · 2 papers
- Theodore Willis Laetsch · 1 paper
- Jochen Buechner · 1 paper
- Susana Rives · 1 paper
- Michael Joseph Boyer · 1 paper
- Henrique Neves da Silva Bittencourt · 1 paper
Papers
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaNew England Journal of Medicine · 2018 · 5,900 citations
BACKGROUND: In a single-center phase 1-2a study, the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel produced high rates of complete remission and was associated with serious but mainly reversible toxic effects in children and young adults with relapsed or…
- Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaNew England Journal of Medicine · 2014 · 5,510 citations
BACKGROUND: Relapsed acute lymphoblastic leukemia (ALL) is difficult to treat despite the availability of aggressive therapies. Chimeric antigen receptor-modified T cells targeting CD19 may overcome many limitations of conventional therapies and induce remission in patients with refractory disease. METHODS: We…
Metadata from OpenAlex (CC0).